Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
aTyr Pharma, Inc. (ATYR) had Weighted-Average Shares Outstanding (Diluted) of 86.49M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-14.88M |
|
-- |
|
-- |
|
$15.77M |
|
$-15.77M |
|
$0.89M |
|
$-14.88M |
|
$-14.88M |
|
$-14.88M |
|
$-14.88M |
|
$-14.88M |
|
$-14.88M |
|
$-15.77M |
|
$-15.91M |
|
86.49M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
86.49M |
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$83.27M |
|
$4.68M |
|
$13.97M |
|
$97.25M |
|
$10.68M |
|
$0.75M |
|
$11.70M |
|
$22.38M |
|
$74.86M |
|
$74.86M |
|
$74.86M |
|
89.00M |
|
| Cash Flow Statement Financials | |
$-15.42M |
|
$-4.42M |
|
$18.63M |
|
$14.01M |
|
$12.79M |
|
$-1.21M |
|
$1.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.79 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.88% |
|
-19.88% |
|
-15.30% |
|
-19.68% |
|
$0.84 |
|
$-0.18 |
|
$-0.18 |
|